GLP-1s and weight loss: Impact on muscles
Roughly 12% of adults in the U.S. are using the injectable drugs known as GLP-1s. These medications include semaglutide (Ozempic) and tirzepatide (Mounjaro). With the use of these medications to help with weight loss and diabetes comes many questions about the long-term impact on health. Although these medications have provided benefits, it is important to keep in mind the effect on the rest of the body to ensure optimal health.